Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Aurobindo Pharma Ltd

NSE: AUROPHARMA

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Aurobindo Pharma Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 90,432.14 Cr.
Price in snapshot: ₹ 1,571.7
ROE: 9.93 %
ROCE: 11.67 %
Dividend Yield: 0.27 %

Snapshot updated 18 October 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 13 August 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings